Loss of FAT1 drives cyclophosphamide resistance in breast cancer via the Wnt/β-Catenin pathway
{{output}}
Drug resistance remains a major obstacle to successful chemotherapy, leading to treatment failure and tumor recurrence. Recent studies indicate that mutations in FAT Atypical Cadherin 1 (FAT1) contribute to drug resistance in cancer cells. However, the precise... ...
